Featured Research

from universities, journals, and other organizations

Benefit Of Aspirin For Healthy People Is Uncertain

Date:
June 2, 2009
Source:
University of Oxford
Summary:
A new study has shown that, while taking aspirin is beneficial in preventing heart attacks and strokes among people with established cardiovascular disease (secondary prevention), its benefits don't clearly outweigh the risks in healthy people (primary prevention).

A new study has shown that, while taking aspirin is beneficial in preventing heart attacks and strokes among people with established cardiovascular disease (secondary prevention), its benefits don’t clearly outweigh the risks in healthy people (primary prevention).
Credit: iStockphoto/Leigh Schindler

A new study has shown that, while taking aspirin is beneficial in preventing heart attacks and strokes among people with established cardiovascular disease (secondary prevention), its benefits don’t clearly outweigh the risks in healthy people (primary prevention).

Related Articles


Researchers at the Clinical Trial Service Unit at the University of Oxford analysed data from a number of primary and secondary prevention trials that had compared long-term aspirin use against controls. The findings are published in The Lancet.

In the primary prevention trials, aspirin reduced the risk of a non-fatal heart attack by about one fifth. This corresponds to five fewer such episodes each year for every 10,000 people treated. This is offset by a comparable increase in bleeds with long-term aspirin use. One extra stroke is caused by bleeding and three extra gastrointestinal bleeds occur each year per 10,000 treated.

In the secondary prevention studies, aspirin reduced the risk of a serious vascular event (a heart attack, stroke or cardiovascular death) by about a fifth. But the risk of an event is much higher among people with established cardiovascular disease, so that there were 150 fewer such events each year for every 10,000 patients treated. This large benefit greatly exceeds the risk of bleeding.

In both sets of trials, the risk of a serious vascular event was reduced to a similar degree in both men and women.

Previous reviews of primary prevention trials have led to guidelines recommending that aspirin be used widely among healthy people who are more at risk of coronary heart disease, having raised blood cholesterol or blood pressure for example.

But the new analyses show that many people with above average risk of coronary heart disease are also at above average risk of suffering a bleed, so this method of selecting whom to treat may not be appropriate.

Professor Colin Baigent, an MRC scientist who led the work at the Clinical Trial Service Unit, says: ‘The primary prevention trials were completed some years ago, when modern drugs such as statins were not widely available. Nowadays, primary prevention with statins and other drugs can safely half the risk of heart attacks and strokes.’

‘When aspirin is added to such drugs, the further reduction in serious vascular events is only about half as large as when it is used alone, but the bleeding risks will remain about the same. This has important implications when judging the likely effects of aspirin in practice.’

The authors conclude: ‘Aspirin is of clear benefit for people who already have cardiovascular disease, but the latest research does not seem to justify general guidelines advocating the routine use of aspirin in all healthy individuals above a moderate level of risk for coronary heart disease.’

When prescribing aspirin to healthy individuals, it is important to consider the potential of such a policy to cause harm. Professor Baigent adds: ‘Drug safety really matters when making recommendations for tens of millions of healthy people. We don’t have good evidence that, for healthy people, the benefits of long-term aspirin exceed the risks by an appropriate margin.’


Story Source:

The above story is based on materials provided by University of Oxford. Note: Materials may be edited for content and length.


Cite This Page:

University of Oxford. "Benefit Of Aspirin For Healthy People Is Uncertain." ScienceDaily. ScienceDaily, 2 June 2009. <www.sciencedaily.com/releases/2009/05/090531115613.htm>.
University of Oxford. (2009, June 2). Benefit Of Aspirin For Healthy People Is Uncertain. ScienceDaily. Retrieved October 24, 2014 from www.sciencedaily.com/releases/2009/05/090531115613.htm
University of Oxford. "Benefit Of Aspirin For Healthy People Is Uncertain." ScienceDaily. www.sciencedaily.com/releases/2009/05/090531115613.htm (accessed October 24, 2014).

Share This



More Health & Medicine News

Friday, October 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

IKEA Desk Converts From Standing to Sitting With One Button

IKEA Desk Converts From Standing to Sitting With One Button

Buzz60 (Oct. 24, 2014) IKEA is out with a new convertible desk that can convert from a sitting desk to a standing one with just the push of a button. Jen Markham explains. Video provided by Buzz60
Powered by NewsLook.com
Ebola Protective Suits Being Made in China

Ebola Protective Suits Being Made in China

AFP (Oct. 24, 2014) A factory in China is busy making Ebola protective suits for healthcare workers and others fighting the spread of the virus. Duration: 00:38 Video provided by AFP
Powered by NewsLook.com
WHO: Millions of Ebola Vaccine Doses by 2015

WHO: Millions of Ebola Vaccine Doses by 2015

AP (Oct. 24, 2014) The World Health Organization said on Friday that millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines would start being tested in March. (Oct. 24) Video provided by AP
Powered by NewsLook.com
Doctor in NYC Quarantined With Ebola

Doctor in NYC Quarantined With Ebola

AP (Oct. 24, 2014) An emergency room doctor who recently returned to the city after treating Ebola patients in West Africa has tested positive for the virus. He's quarantined in a hospital. (Oct. 24) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins